Navigation Links
Biothera's Imprime PGG Enhanced Effectiveness of Avastin in Cancer,Study

e I clinical trials under its cancer Investigational New Drug (IND) application for the use of Imprime PGG in combination with anti-cancer monoclonal antibodies. Under a separate IND, the company also has completed a Phase I/II trial with Imprime PGG in combination with a hematopoietic growth factor.

Biothera plans to initiate multiple Phase Ib and Phase II studies with Imprime PGG in combination with anti-cancer monoclonal antibodies.

About Avastin(R)

Avastin is the first U.S. Food and Drug Administration (FDA) approved therapy designed to inhibit angiogenesis, the process by which new blood vessels develop and carry vital nutrients to a tumor. Avastin is approved, in combination with intravenous 5-fluorouracil-based (5-FU) chemotherapy, for first- or second-line treatment of patients with metastatic carcinoma of the colon or rectum and in combination with carboplatin and paclitaxel for the first-line treatment of patients with unresectable, locally advanced, recurrent or metastatic non-squamous non-small cell lung cancer (NSCLC). Avastin is a product of Genentech.

About Biothera, the Immune Health Company

Biothera is a biotechnology company dedicated to improving immune health. The company's primary focus is developing pharmaceuticals that engage the innate immune system to fight cancer. Other applications include hematopoiesis (production of blood cells) and infectious disease. In addition, Biothera manufactures and markets food-grade ingredients that support healthy immune function to the nutritional supplement, functional food, cosmetic and animal nutrition markets. Website: www.biotherapharma.com.

Contact

Biothera, the Immune Health Company
David Walsh, 651-256-4606
VP, Communications
dwalsh@biotherapharma.com


'"/>




Page: 1 2

Related medicine technology :

1. Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting
2. Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma
3. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
4. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
5. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
6. St. Jude Study Shows Effectiveness of Peramivir in Prevention of Mortality in Mouse Model of Avian Influenza H5N1 Virus Infection
7. Study Supports Cost-Effectiveness of Medtronics Spasticity Treatment for Children with Cerebral Palsy
8. FDA MedWatch: Avastin (bevacizumab) and Formation of Tracheoesophageal Fistula in a Recent Clinical Study in Patients with Limited-stage Small Cell Lung Cancer
9. Data Presented at AACR Meeting Shows Peregrines Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models
10. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
Post Your Comments:
(Date:11/25/2008)...spondents against expanding statin use broadly in ...S, N.J., Nov. 25 JUPITER, a clinic...diovascular risk of healthy patients with elevated...der adults, according to a national poll directed ...ook part in the online poll conducted by medical n...
(Date:11/25/2008).... 25 Pharmacyclics, Inc....ny has completed a Phase 1,clinical trial with PC...l-molecule Factor VIIa inhibitor. The trial was co...luate the safety and pharmacologic effect of,PCI-...ed in a linear dose,response in the International...
(Date:11/24/2008)...SAKA, Japan, Nov. 24 Takeda Pharma...idiary, Takeda Global Research & Development C...tis Advisory Committee of the U.S. Food and Drug A...ve febuxostat for the treatment of hyperuricemia ...favor of approval, with one panel member abstainin...
(Date:11/24/2008)... Cancer Awareness Month , , Oak Brook, Ill.... Society for Gastrointestinal Endoscopy (ASGE) and...up this November to raise awareness about pancreat...d the resources that are available for them. , ...e of cancer deaths in the U.S. In 2008, an estimat...
Breaking Medicine Technology:Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6New Survey Finds Overwhelming Majority of Working Americans Not Financially Prepared for Disability Would Rely on Sources Other than Themselves for S 19037 1New Survey Finds Overwhelming Majority of Working Americans Not Financially Prepared for Disability Would Rely on Sources Other than Themselves for S 19037 2New Survey Finds Overwhelming Majority of Working Americans Not Financially Prepared for Disability Would Rely on Sources Other than Themselves for S 19037 3New Survey Finds Overwhelming Majority of Working Americans Not Financially Prepared for Disability Would Rely on Sources Other than Themselves for S 19037 4History Making Obesity Awareness Event Scheduled to Take Place in Washington DC on June 17 2008 19035 1History Making Obesity Awareness Event Scheduled to Take Place in Washington DC on June 17 2008 19035 2Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 5312 1Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 5312 2Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 5312 3Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 5312 4Shire Launches Nationwide Adult ADHD Mobile Awareness Tour 5312 5Ancient protein offers clues to killer condition 3266 1Ancient protein offers clues to killer condition 3266 2
...720 Mechanisms in Multiple,Sclerosis May Include D... studies suggest FTY720 stimulates cells,that may ...f the,CNS affected by multiple sclerosis , ·...,sclerosis Phase II clinical study found that the ...s significantly lower in the,FTY720 groups compare...
...)--May 4, 2007 - New data from a,randomized, doubl...E(R) (glatiramer acetate injection) along with the... (Gd)-enhancing lesions,of the brain by 63 percent...ing multiple sclerosis (RRMS), as measured by,magn...ceiving,COPAXONE(R) alone. Additionally, the nine-...
Other Medicine Technology:Data to be presented at AAN Meeting -Study results of drug,candidate for MS 2Data to be presented at AAN Meeting -Study results of drug,candidate for MS 3Data to be presented at AAN Meeting -Study results of drug,candidate for MS 4Data to be presented at AAN Meeting -Study results of drug,candidate for MS 5Data to be presented at AAN Meeting -Study results of drug,candidate for MS 6Data to be presented at AAN Meeting -Study results of drug,candidate for MS 7Data to be presented at AAN Meeting -Study results of drug,candidate for MS 8Data to be presented at AAN Meeting -Study results of drug,candidate for MS 9Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5
(Date:12/2/2008)...lifornia Health System Builds Resilient, Cost and ..., HOPKINTON, Mass., Dec. 2 EMC ...formation infrastructure solutions, today announce...S), a regional system of six hospitals spanning th...ervers and implemented business continuity functio...
(Date:12/2/2008)...NVER, Dec. 2 Barotz Dental is now ...ng LANAP(TM) (Laser Assisted New Attachment,Proce...col that is patented,and FDA approved for new att... LANAP removes diseased tissue, without removin...sue around teeth, minimizes pain and discomfort to...
(Date:12/2/2008)...SHERS, Ind., Dec. 2 A number of re...e in childhood obesity, the health risks in,overw...alue of cereals and,other foods kids consume. Ye...offers all natural, freeze-dried real fruit produc... but also provide most, if not all, of the daily f...
(Date:12/2/2008)... Zicam Cold & Flu Compa...ers stay one step ahead of cold and flu. , ...er 2, 2008 -- Matrixx Initiatives, Inc., makers of...h of the Zicam® Cold & Flu Companion mobil...d,s first Android-powered phone. The same mobile a...
Breaking Medicine News(10 mins):Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 2Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 3Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 4Health News:Barotz Dental Now Offering Laser Gum Therapy 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 3Health News:Zicam Launches "Cold & Flu Companion" Mobile Application 2Health News:Zicam Launches "Cold & Flu Companion" Mobile Application 3
...ing weight by dietary changes and increased physic...condition where blood glucose// levels are higher ...ese are the results of a new study that was publis...Care, of women who participated in the Diabetes Pr...
...e being hit the most by obesity-related disorders....ne by doctors that fails to// detect these problem...ight divided by height- is used in the standard me...ing to the experts, East and South Asians were aff...
...n Canada ahead of HIV/AIDS, diabetes and car accid...inal communities. With World// Suicide Prevention ... from the Canadian Institutes of Health Research (...lenges posed by suicide, its causes and possible p...
...er a period of 30 years and has infected many peop...Recently, 3 people in Delhi// have tested positive...rs who transmit chikungunya fever to human. The N...able Diseases (NICD) tested 6 blood samples of whi...
Other Medicine News:Health News:Bladder Control following Weight loss in women with Prediabetes 2Health News:Bladder Control following Weight loss in women with Prediabetes 3Health News:Getting Serious About Suicide Prevention 2
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients.
BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology.
Inquire
The inner wall of the tube is coated with spray-dried lithium, ammonium or sodium heparin. These additives are anti-coagulants, which activate anti-thrombins, thus blocking the coagulation cascade of
Medicine Products: